G1 Therapeutics Inc (GTHX)
4.31
+0.06
(+1.53%)
USD |
NASDAQ |
May 08, 10:21
G1 Therapeutics Profit Margin (Quarterly): -70.59% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -70.59% |
December 31, 2023 | -73.14% |
September 30, 2023 | -148.0% |
June 30, 2023 | 20.55% |
March 31, 2023 | -213.2% |
December 31, 2022 | -328.3% |
September 30, 2022 | -107.2% |
June 30, 2022 | -373.1% |
Date | Value |
---|---|
March 31, 2022 | -712.7% |
December 31, 2021 | -690.5% |
September 30, 2021 | -874.2% |
June 30, 2021 | -596.9% |
March 31, 2021 | -186.0% |
December 31, 2020 | -153.2% |
September 30, 2020 | -43.89% |
June 30, 2020 | -1.46K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.46K%
Minimum
Jun 2020
20.55%
Maximum
Jun 2023
-375.5%
Average
-199.6%
Median
Profit Margin (Quarterly) Benchmarks
Amicus Therapeutics Inc | -29.41% |
Geron Corp | -18.22K% |
Palatin Technologies Inc | -385.6% |
Oragenics Inc | -- |
TG Therapeutics Inc | -16.87% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -73.30% |
Return on Assets | -22.95% |
Return on Invested Capital | -31.67% |
Gross Profit Margin (Quarterly) | 92.55% |
Operating Margin (Quarterly) | -62.50% |
Return on Net Operating Assets | -91.97% |